Evidence map›Paper›PMID 29995270›Full record

ArticleMolecular biology reports2018

Machine learning algorithm-based risk prediction model of coronary artery disease.

Shaik Mohammad Naushad, Tajamul Hussain, Bobbala Indumathi, Khatoon Samreen, Salman A Alrokayan, Vijay Kumar Kutala

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Shaik Mohammad NaushadSandor Lifesciences Pvt Ltd, Banjara Hills, Road No. 3, Hyderabad, India. naushad@sandor.co.in.ORCID http://orcid.org/0000-0001-8952-9581
Tajamul HussainCenter of Excellence in Biotechnology Research, College of Science, King Saud University, Riyadh, Saudi Arabia.ORCID http://orcid.org/0000-0002-6770-9108
Bobbala IndumathiDepartment of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, India.ORCID http://orcid.org/0000-0002-8385-0865
Khatoon SamreenSandor Lifesciences Pvt Ltd, Banjara Hills, Road No. 3, Hyderabad, India.
Salman A AlrokayanDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Vijay Kumar KutalaDepartment of Clinical Pharmacology and Therapeutics, Nizam's Institute of Medical Sciences, Hyderabad, India.ORCID http://orcid.org/0000-0002-7253-8999
King Saud University · SANizam's Institute of Medical Sciences · INSanden (Japan) · JP

Funding

Deanship of Scientific Research at King Saud University RG-1435-066
6 · The paper itself

Abstract

In view of high mortality associated with coronary artery disease (CAD), development of an early predicting tool will be beneficial in reducing the burden of the disease. The database comprising demographic, conventional, folate/xenobiotic genetic risk factors of 648 subjects (364 cases of CAD and 284 healthy controls) was used as the basis to develop CAD risk and percentage stenosis prediction models using ensemble machine learning algorithms (EMLA), multifactor dimensionality reduction (MDR) and recursive partitioning (RP). The EMLA model showed better performance than other models in disease (89.3%) and stenosis prediction (82.5%). This model depicted hypertension and alcohol intake as the key predictors of CAD risk followed by cSHMT C1420T, GCPII C1561T, diabetes, GSTT1, CYP1A1 m2, TYMs 5'-UTR 28 bp tandem repeat and MTRR A66G. MDR and RP models are in agreement in projecting increasing age, hypertension and cSHMTC1420T as the key determinants interacting in modulating CAD risk. Receiver operating characteristic curves exhibited clinical utility of the developed models in the following order: EMLA (C = 0.96) > RP (C = 0.83) > MDR (C = 0.80). The stenosis prediction model showed that xenobiotic pathway genetic variants i.e. CYP1A1 m2 and GSTT1 are the key determinants of percentage of stenosis. Diabetes, diet, alcohol intake, hypertension and MTRR A66G are the other determinants of stenosis. These eleven variables contribute towards 82.5% stenosis. To conclude, the EMLA model exhibited higher predictability both in terms of disease prediction and stenosis prediction. This can be attributed to higher number of iterations in EMLA model that can increase the prediction accuracy.

Indexed as

AdultAgedAlgorithmsCase-Control StudiesCoronary Artery DiseaseCytochrome P-450 CYP1A1Epistasis, GeneticFemaleFolic AcidForecastingGenetic Predisposition to DiseaseGlycine HydroxymethyltransferaseHumansMachine LearningMaleMiddle AgedCYP1A1 protein, humanCytochrome P-450 CYP1A1Folic AcidGlycine HydroxymethyltransferaseSHMT protein, humanXenobioticsCoronary artery diseaseEnsemble machine learning algorithmFolate and xenobiotic pathwaysMultifactor dimensionality reductionRecursive partitioning

Identifiers

PMID29995270
OpenAlexW2891822621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.